Recombinant Human AXL protein (rFc Tag)

种属

Human

纯度

>90 %, SDS-PAGE

标签

rFc Tag

生物活性

未测试

Cat no : Eg1618

Print datasheet

Synonyms

EC:2.7.10.1, Tyrosine-protein kinase receptor UFO, UFO



产品信息

纯度 >90 %, SDS-PAGE
内毒素 <0.1 EU/μg protein, LAL method
生物活性 Not tested
来源 HEK293-derived Human AXL protein Glu33-Pro449 (Accession# P30530-1) with a rabbit IgG Fc tag at the C-terminus.
基因ID 558
蛋白编号 P30530-1
预测分子量 71.4 kDa
SDS-PAGE 75-110 kDa, reducing (R) conditions
组分 Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
复溶 Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
储存条件
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
运输条件 The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

背景信息

Axl, also known as Ufo or Ark, is a receptor tyrosine kinase of the TAM (Tyro3, Axl and Mer) family. Axl is a single-pass type I membrane protein containing two fibronectin type-III domains, two Ig-like C2-type domains and one protein kinase domain. Axl mRNA is widely expressed with highest levels in the heart and skeletal muscle. Gas6 has been identified as a ligand for human Axl. Gas6/Axl signaling plays a role in cell survival, cell proliferation, migration and differentiation. Activation of Axl induces a broad range of activities including platelet aggregation and thrombus formation, macrophage and dendritic cell phagocytosis of apoptotic cells, NK cell development from hematopoietic progenitor cells, and in vivo angiogenesis.

参考文献:

1. Markus Lauter, et al. (2019) Cell Commun Signal. 17(1):59. 2. J M E M Cosemans, et al. (2010) J Thromb Haemost. 8(8):1797-808. 3. Il-Kyoo Park, et al. (2009) Blood. 113(11):2470-7. 4. Heather M Seitz, et al. (2007) J Immunol. 178(9):5635-42. 5. Sacha J Holland, et al. (2007) Cancer Res. 65(20):9294-303.